PON1 and hepatocellular carcinoma: Serum paraoxonase 1 (PON1) is a highly fucosylated glycoprotein in HCC compared with LC, with an AUROC of 0.892, sensitivity of 71.4%, and specificity of 94.7% in differentiating early HCC from LC (93).